RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
Objective. Comparison of Axoglatiran® FS (F-Sintez, Russia) and Copaxone®-Teva (Teva Pharmaceutical Industries Ltd., Israel) efficiency and safety in patients with relapsing-remitting multiple sclerosis. Materials and methods. In the study 150 patients with relapsing-remitting multiple sclerosis w...
Saved in:
Main Authors: | F. A. Khabirov, T. I. Khaibullin, E. V. Granatov, N. N. Babicheva, L. A. Aver’yanova, S. R. Shakirzyanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2017-01-01
|
Series: | Нервно-мышечные болезни |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/177 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Excess Value Created as a Performance Metric and its Determination Utilizing the <i>TEVA</i> Measure
by: R. G. Ibragimov
Published: (2022-04-01) -
Copaxone in therapy of remittent disseminated sclerosis patients
by: O. A. Kitcherova, et al.
Published: (2008-09-01) -
Positive and Negative Aspects of Copaxone ( Glatiramer acetate) Action on TC, TG HbA1c and Iron Levels in The Sera of Iraqi Women with Multiple Sclerosis in Baghdad
by: Baghdad Science Journal
Published: (2017-03-01) -
Manas mātes un tēva dzimtas un viņu dzīves gaitas
by: Alksnis, Jēkabs
Published: (1999-01-01) -
Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)